What is the risk of uterine perforation during a repeat (second) myomectomy in a typical premenopausal woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Uterine Perforation Following Second Myomectomy

The available evidence does not provide specific data on uterine perforation rates during repeat myomectomy procedures. However, based on the broader surgical literature and related procedures, the risk can be contextualized through understanding of myomectomy complications and factors that increase surgical difficulty.

What the Evidence Shows About Myomectomy Complications

Primary Myomectomy Risks

The guideline literature focuses primarily on other complications rather than perforation:

  • Postoperative adhesions are identified as a major risk of myomectomy, occurring at incision sites and as de novo adhesions from peritoneal trauma 1
  • Uterine rupture during subsequent pregnancy is the most emphasized complication, particularly when the uterine cavity is entered during surgery 1
  • The recommendation is to wait 2-3 months before attempting pregnancy after myomectomy to allow uterine incisions to heal 1

Comparative Perforation Data from Related Procedures

While direct data on repeat myomectomy perforation is absent, hysteroscopic surgery provides relevant context:

  • Uterine perforation during hysteroscopic procedures occurs at a rate of 1.61% overall 2
  • Perforation risk is highest during adhesiolysis (synechiolysis), which is relevant because repeat myomectomy involves operating through scar tissue 2
  • In 97% of perforations during hysteroscopy, the complication was recognized intraoperatively with no subsequent complications when managed appropriately 2

Factors That Increase Risk in Repeat Surgery

Surgical Complexity in Repeat Procedures

A second myomectomy inherently carries higher technical difficulty due to:

  • Adhesions from the first surgery create altered anatomy and obscure tissue planes 1
  • Scar tissue in the myometrium makes dissection more challenging and increases the risk of inadvertent entry into the uterine cavity 3
  • Distorted uterine architecture from previous surgery complicates identification of fibroid borders 3

Recurrence Patterns That Affect Surgical Risk

  • Multiple fibroids at initial surgery significantly increase recurrence risk (38.71% recurrence rate) 4
  • Age 30-40 years at first surgery is associated with 31.25% recurrence risk 4
  • The cumulative 10-year recurrence rate after myomectomy is 27% 1

Clinical Implications and Risk Mitigation

Preoperative Considerations

Before proceeding with a second myomectomy, consider:

  • Imaging assessment to map fibroid location relative to previous surgical sites and assess for cavity involvement 3
  • Patient counseling about increased technical difficulty and the possibility of conversion to hysterectomy if complications arise 3
  • Surgical expertise is crucial, as training and experience directly reduce complication rates 3

Intraoperative Strategies to Minimize Perforation Risk

  • Careful port placement determines ergonomic performance and surgical difficulty 3
  • Appropriate hysterotomy length relative to fibroid size decreases bleeding and surgical time 3
  • Meticulous myometrial repair is essential, particularly for women desiring future pregnancy, to minimize uterine rupture risk 5, 6

Common Pitfalls to Avoid

  • Underestimating adhesive disease from the first surgery leads to inadequate surgical planning 1
  • Inadequate multilayer myometrial closure increases both perforation risk during surgery and rupture risk in subsequent pregnancy 5
  • Failure to recognize intraoperative perforation can lead to delayed diagnosis and complications, though this is rare when vigilance is maintained 2

Alternative Considerations

Given the lack of specific perforation data and the known increased complexity of repeat surgery, alternative treatments should be discussed:

  • Uterine artery embolization achieves 40-50% volume reduction with 80% symptomatic control and technical success >95% 1
  • Hysterectomy remains definitive therapy with very high patient satisfaction when fertility is not desired 1
  • Repeat embolization has been shown effective for recurrent symptoms after initial UAE 1

1, 3, 5, 2, 6, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Risk of uterine perforation during hysteroscopic surgery.

The Journal of the American Association of Gynecologic Laparoscopists, 2002

Research

Long-term risk of fibroid recurrence after laparoscopic myomectomy.

European journal of obstetrics, gynecology, and reproductive biology, 2014

Research

Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.

The Cochrane database of systematic reviews, 2014

Related Questions

Why do doctors prescribe dydrogesterone (a progestogen) to women of reproductive age with a history of uterine fibroids after a myomectomy?
When can a patient start physical therapy after an uncomplicated myomectomy, and does the timeline differ between minimally invasive (laparoscopic or robotic) and open abdominal approaches?
How to remove a fibroid specimen after laparoscopic myomectomy?
What are some multiple-choice questions (MCQs) for diploma students to assess their knowledge on laparoscopy basics, hysterectomy, myomectomy, and hysteroscopy?
What are the post-operative instructions for patients undergoing laparoscopic myomectomy?
What are the detailed clinical features and treatment guidelines for eosinophilic pneumonitis?
I have an itchy periorbital rash without pain, swelling, or visual changes; how should I evaluate and manage it?
What is the probability of a uterine‑abdominal fistula after abdominal or laparoscopic myomectomy in a typical premenopausal woman?
How should I manage nivolumab‑induced thyrotoxicosis in a patient receiving nivolumab who develops symptoms such as palpitations, heat intolerance, weight loss, tremor, or tachycardia?
What is the recommended treatment approach for breast cysts and fibrocystic breast changes (fibroadenosis) in reproductive‑age women?
How should pneumonia be managed in an adult immunocompromised patient, such as one with neutropenia, solid‑organ or hematopoietic‑cell transplant, high‑dose steroids, or HIV with CD4 count <200 cells/µL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.